MENU

INM

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

InMed Pharmaceuticals (INM) Ownership - Who owns InMed Pharmaceuticals?

InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

885 West Georgia Street

Phone

+1 604 669-7207

Employees

13

Web

https://www.inmedpharma.com

Details

Group

Domestic Stock Funds

Category

Pharmaceuticals

Capitalization

8.49M

P/E Ratio

0.01

Total Cash

5.16M

Projected Growth

N/A

Total Debt

420.15K

Revenue

4.94M

Risk (Beta)

2.73

Dividend Yield

N/A

Total Cash/Share

0.97

Total Debt/Equity

N/A

Revenue/Share

1.47 USD as % of share price

View a ticker or compare two or three

VS

VS

INM

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for INM

A.I. Advisor

published General Information

General Information

Industry PharmaceuticalsGeneric

Profile

Details

Industry

N/A

Address

885 West Georgia Street

Phone

+1 604 669-7207

Employees

13

Web

https://www.inmedpharma.com